摘要 |
<p>The present invention relates to a pharmaceutical composition comprising an oligosaccharide capable of binding to lipoprotein lipase and to the use of said pharmaceutical composition in the prevention or treatment of diseases involving uptake of lipoprotein in mammalian cells, particularly for the prevention or treatment of atherosclerosis.</p> |